No Detail Found!

Determination Of Specificity And Pattern Of Antinuclear Antibodies (ANA) In Systemic Rheumatic Disease Patients Positive For Ana Testing.

Author(s)
Hamid Nawaz Tipu Department of Immunology, Armed Forces Institute of Pathology (AFIP), Rawalpindi, Pakistan
Muhammad Mukarram Bashir Department of Immunology, Armed Forces Institute of Pathology (AFIP), Rawalpindi, Pakistan
Waseem Iqbal Department of Immunology, Armed Forces Institute of Pathology (AFIP), Rawalpindi, Pakistan
Abstract
Objective: To determine probability of finding antinuclear antibodies (ANA) and anti extractable nuclear antigens (ENA) positive samples and associating ANA patterns with anti-ENA reactivities among a consecutive cohort of samples of systemic rheumatic disease patients referred for ANA testing. Study Design: Prospective cohort study. Place and Duration of Study: Immunology Department, Armed Forces Institute of Pathology, Rawalpindi, Pakistan, from January to June 2016. Methodology: All the samples referred for ANA testing with clinical suspicion of systemic rheumatic disease were included. After screening, ANA positive samples were subjected to anti-ENA antibodies testing (including anti-SSA, antiSSB, anti-Sm, anti-RNP, anti-SCL-70 and anti-Jo-1 antibodies) and ANA pattern and titer determination. Results: Of 4,347 samples received, 397 were positive for ANA (9%). Of 397, 96 (24%) samples positive on ENA screen were tested for anti-ENA reactivity. Anti-SSA antibodies were found in 59 samples. Commonest ANA patterns were coarse and fine speckled (43 and 22 samples of 81 tested), while majority of samples carried ANA in titers of 1:40 and 1:80 (22 and 18 samples of 81 tested). No specific ANA pattern was associated with any particular anti-ENA reactivity. Conclusion: Among samples/patients referred for investigations of autoimmune disorders, probability of finding positive ANA is approximately 9%. Of these 9%, about 24% also show reactivity against ENA. Commonest ANA pattern is coarse speckled and majority of such patients carry ANA in titers ranging from 1:40 to 1:80. Commonest ENA reactivity was against SSA.
Publication Details
Page(s) 40-43
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 28, Issue: 1, Year: 2018

Request the full text from PASTIC

References
SatohM,ChanEKL,HoLA,RoseKM,ParksCG,CohnRD, 2012.Prevalence and sociodemographic correlates of antinuclear antibodies in the United States,Arthritis Rheum 64 2319 -27
FritzlerMJ, 2011.The antinuclear antibody test: Last or lasting gasp,Editorial. Arthritis Rheum 63 19 -22
BeeckKOD,VermeerschP,VerschuerenP,WesthovensR,MarienG,BlockmansD, 2011.Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay,Autoimmun Rev 10 801 -8
AbelesAM,Gomez-RamirezM,AbelesM,Honiden S, 2016.Antinuclear antibody testing: discordance between commercial laboratories,Clin Rheumatol 35 1713 -8
SotoME,Hernandez-BercerrilN,Perez-ChineyAC,Hernandez-RizoA,Telich-TarribaJE,Juarez-OrozcoLE, 2015.Predictive value of antinuclear antibodies in autoimmune diseases by clinical criteria: Analytical study in a specialized health institute, one year follow-up,Res Immunol 5 13 -22
DamoiseauxJGMC,TervaertJWC, 2006.,Autoimmun Rev 5 10 -7
OrtonSM,Peace-BrewerA,SchmitzJL,FreemanK,MillerWC,FoldsJD, 2004.Practical evaluation of methods for detection and specificity of autoantibodies to extractable nuclear antigens,Clin Diagn Lab Immunol 11 297 -301
GautamK., 2015.Anti-nuclear antibodies: Current concepts and future direction for diagnosing connective tissue disease,J Pathol Nepal 5 766 -73
BaronaiteR,EngelhartM,HansenTM,ThamsborgG,JensenHS,StenderS, 2014.A comparison of anti-nuclear antibody quantification using automated enzyme immunoassay and immunofluorescence assays,Autoimmune diseases 8 -
PhanTG,WongRCW,AdelsteinS., 2002.Autoantibodies to extractable nuclear antigens: Making detection and interpretation more meaninglful,Clin Diagn Lab Immunol 9 1 -7
TipuHN, 2011.Frequency of antinuclear autoantibodies among healthy volunteers,Pak Armed Forces Med J 61 4 -
MinzRW,KumarY,Anand S. SinghS,BamberiP,VermaS, 2012.Antinuclear antibody positive autoimmune disorders in North India: an appraisal,Rheumatol Int 32 2883 -8
GuoYP,WangCG,LiuX,HuangYQ,GuoDL,JingXZ, 2014.The prevalence of antinuclear antibodies in the general population of China: A cross-sectional study,Curr Ther Res Clin Exp 76 116 -9
AhmedS, 2014.Association of immunofluorescence pattern of antinuclear antibody with specific autoantibodies in the Bangladeshi population,Bangladeh Med Res Counc Bull 40 74 -8
StamouliM,SklirisA,ReppaD,MaganakiE,TotosG, 2013.Detection of antinuclear antibodies (ANA), antibodies to double stranded DNA (ant-dsDNA) and antibodies to extractable nuclear antigens (anti-ENA) in Greek patients,Clin Lab 59 283 -91
PeeneI,MeheusL,VeysEM,De Keyser F, 2001.Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing,Ann Rheum Dis 60 1131 -6
BremerHD,LattweinE,RennekerS,LilliehookI,RonnelidJ,Hansson-Hamlin H, 2015.Identification of specific antinuclear antibodies in dogs using a line immunoassay and enzymelinked immunosorbent assay,Vet Immunol Immunopathol 168 233 -41
VoigtJ,KrauseC,RohwaderE,SaschenbreckerS,HahnM,DanckwardtM, 2012.,Automated indirect immunofluorescence evaluation of antinuclear autoantibodies on HEp-2 cells. Clin Dev Immuno 651058 -
0

Citations

0

Downloads

135

Views